New microchip separates tumour cells in blood stream

NewsGuard 100/100 Score

Ikerlan-IK4 and Mondragón Unibertsitatea are taking part in a project initiated by the Spanish National Research Council, CSIC, and which has developed a microchip capable of separating and extracting tumour cells in the blood stream by means of ultrasonic waves. The Foundation General Hospital of the University of Elche, together with researcher Alfredo Carrato, has also collaborated on this project.

The patented microchip has the size of a one euro coin, incorporating a small channel along which a sample of blood containing the patient's tumour cells flows. By means of ultrasonic waves focused on a specific zone, these cells, having a density and size different from the rest, concentrate at the point from where they are gathered.

The device, made of plastic, has potential advantages in the detection of metastasis in its initial phases, and in the control of the effectiveness of the therapy applied to cancer patients. It is made up of an acoustic wave piezoelectric generator, a microchip and a fluidic capsule.

Another of the unique features is that the process is totally non-invasive, given that there is no need to introduce any foreign object into the blood sample in order to detect tumour cells circulating in the blood. Moreover, it maintains the properties of the cells so that subsequent studies or biomolecular analyses can be carried out.

The next stage is developing an industrial-scale prototype. To this end, the research team is already working on perfecting the microchip, and on developing a system for the automatic detection and count of the tumour cells.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spicing up diabetes management: Mediterranean diet's aromatic herbs lower blood sugar